- Release Date: 25/02/15 08:30
- Summary: HALFYR: ATM: Half Year results for the period ending 31 December 2014
- Price Sensitive: No
- Download Document 5.04KB
ATM 25/02/2015 08:30 HALFYR PRICE SENSITIVE REL: 0830 HRS The a2 Milk Company Limited HALFYR: ATM: Half Year results for the period ending 31 December 2014 25 February 2015 The a2 Milk Company Limited Chairman's Report Dear Shareholder I am pleased to report on the continuing progress of The a2 Milk Company Limited ("the Company" or "a2MC") during the six months to 31 December 2014. The Company and its subsidiaries ("the Group") achieved Group revenue of $74.79 million and Group profit after tax of $0.13 million, reflecting the strong growth in the Australian business and continued investment in our strategic growth initiatives as we fund expansion into international markets. The balance sheet position remained strong with cash on hand at the balance sheet date of $9.86 million. During the period, the Australian business performed exceptionally well as it continued along its growth trend with sales and profit well ahead of the corresponding period last year. In the UK, progress is being made on the implementation of the revised business model, having received broad product acceptance with a growing retail distribution base. We have recommenced sales to China and continue to work on the establishment of strong distribution networks in the region. The USA market entry plan is near complete, with a launch expected in fourth quarter of FY15. On 18 November 2014, the Company announced plans to seek a listing on the Australian Securities Exchange ("ASX") in addition to its New Zealand Exchange ("NZX") Listing. It is expected the listing will enable more Australian investors to participate in the Company's growth, will improve the liquidity of the Company's shares and will closer align the Company's capital markets profile and business operations. This process is well progressed and the application for the listing of the Company's securities on the ASX is imminent. The CEO's report contains further detail on the Group's operational performance. I wish to thank our management, staff and my fellow Directors for their significant efforts and also our customers, business partners and shareholders for their continued support. Best regards CJ Cook Chairman 24 February 2015 CEO's Report Overview The Group performed ahead of plan during the period and its strategic growth initiatives continued to gain momentum. The Company's strategic plan is based on funding growth in priority international markets from increasing Australian profits. The Australian business achieved a record revenue and earnings result and the UK business achieved milestones consistent with the revised plan. The China infant formula business has been repositioned in response to the changes in regulation of imports during 2014, and the planning for the launch of a2 Milk(TM) into the United States in coming months has been progressed. As foreshadowed at the general meeting in November 2014, the Company is finalising an application for the listing of its securities on the Australian Securities Exchange ("ASX") in addition to its existing NZX listing. The unaudited Group profit after tax for the 6 months ended 31 December 2014 was $125,000 and included: - Total revenue of $74.79 million, an increase of 38% over the prior corresponding period ("PCP"); - Group EBITDA of $3.27 million before non-recurring items, an increase of 27% over the PCP; - EBITDA after inter-company charges for the Australian and New Zealand operations of $4.88 million, an increase of 113% on the PCP; - EBITDA associated with establishing the UK business of ($1.92) million after inter-company charges; - EBITDA associated with establishing the China business of ($0.61) million after inter-company charges; - Corporate EBITDA after inter-company charges of $0.92 million (before non-recurring items of $0.76 million); and - Income tax charge of $1.56 million. The higher income tax charge represents higher nondeductible expenses (mainly related to development and ASX listing costs), and UK losses not tax effected. The balance sheet at 31 December 2014 includes cash on hand of $9.86 million. The operating cash outflow for the half primarily reflects an increase in working capital associated with the growth in infant formula and milk sales. Management believes that the 2016 revenue projection of $230 million advised in the 2014 annual report remains appropriate. Whilst meaningful revenue from China and the UK is yet to emerge, these businesses are gaining traction and the Australian business continues to outperform expectations. In addition, sales in the USA market are expected to compensate for any shortfall in other markets. Australian growth continues strongly The Australian and New Zealand business continued to perform strongly with sales growth and operating earnings in Australia well ahead of the PCP. Total revenue growth for the Australian and New Zealand business relative to the PCP was ~39%. EBITDA before intercompany charges was $13.96 million. (Please see attachment for the remainder of CEO's report) Geoffrey Babidge Chief Executive Officer 24 February 2015 End CA:00261068 For:ATM Type:HALFYR Time:2015-02-25 08:30:03
Ann: HALFYR: ATM: Half Year results for the period ending 31 December 2014
Add to My Watchlist
What is My Watchlist?